Theratechnologies inc.
TSX : TH

Theratechnologies inc.

March 21, 2006 08:42 ET

Theratechnologies Closes $20 475 000 Bought Deal

MONTREAL, QUEBEC--(CCNMatthews - March 21, 2006) - Not for distribution to U.S. news wire services or dissemination in the United States.

Theratechnologies Inc. (TSX:TH) announces today that it has successfully completed its recently announced offering of 10,500,000 common shares to a syndicate of underwriters led by BMO Nesbitt Burns at a price of $1.95 per share for gross proceeds of $20,475,000. The underwriters also have an option, exercisable within 30 days of the closing date, to acquire up to an additional 1,575,000 common shares for purposes of covering over-allotments and for market stabilization.

The proceeds of the offering will be used to finance Theratechnologies' research and development expenditures (mainly the two Phase 3 clinical studies for TH9507 in HIV-associated lipodystrophy) and additional working capital requirements.

The securities offered have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.

Annual General Meeting Set

Theratechnologies' Annual Meeting of Shareholders will be held on Thursday, March 30, at 10:00 a.m., at the Centre Mont-Royal, 2200 Mansfield, Montreal.

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers or acquires novel therapeutic products for development and commercialization. These products target unmet medical needs in commercially attractive specialty markets. The most advanced program is in Phase 3 clinical development in HIV-associated lipodystrophy. The Company also has other promising projects at various stages of development.

Additional information about Theratechnologies

Further information relating to Theratechnologies is available on the Company's website at http://www.theratech.com. The Company is listed on the Toronto Stock Exchange under the symbol TH. Additional information, including the Company's Annual Information Form, is available on SEDAR at www.sedar.com.

Contact Information